The effects of cyclic peptide [R4W4] in combination with first-line therapy on the survival of Mycobacterium avium

The effects of cyclic peptide [R4W4] in combination with first-line therapy on the survival of Mycobacterium avium

BackgroundMycobacterium avium (M. avium) is a nontuberculous mycobacterium (NTM) that can cause pulmonary and extrapulmonary infections mostly in immunocompromised individuals, such as those with HIV and diabetes. Traditionally, rifampicin (RIF) and azithromycin (AZ) have been used for a 12-month du...

Full description

Saved in:
Bibliographic Details
Main Authors: Melissa Kelley, Kayvan Sasaninia, Ali Badaoui, Ira Glassman, Arbi Abnousian, Nadia Rai, Rakesh K. Tiwari, Vishwanath Venketaraman
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Mycobacterium avium
antimicrobial
cyclic peptide
antibiotics
macrophages
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1547376/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2025.1547376/full

Similar Items